References
- SHIRKEY FL Editorial comment: therapeutic orphans. J. Pediatr. (1968) 72(1)119–120. An editorial of historical interest as it is the first to define clearly the problem of insufficient paediatric dosing information.
- KAUFFMAN RE: Status of drug approval processes and regulation of medications for children. Cutr. Opin. Pediatr. (1995) 7(2):195–198.
- GILMAN JT, GAL P: Pharmacolcinetic and pharmacody-namic data collection in children and neonates: a quiet frontier. Chn. Pharmacokinet. (1992) 23(1):1–9
- COMMITTEE ON DRUGS: Guidelines for the Ethical Con-duct of studies to evaluate drugs in pediatric popula-tions. Pediatr. (1995) 95(2):286–294. A complete description of the ethical considerations which are unique to paediatric drug research with guidelines to ensure that the rights of individual children are respected.
- WILSON JT, KEARNS GL, MURPHY D, YAFFE SJ: Paediatric labelling requirements: implications for pharmacolci-netic studies. Clin. Pharmacokinet. (1994) 26(4):308–325.
- MORSELLI PL: Clinical pharmacology of the perinatal period and early infancy. Clin. Pharmacokinet. (1989) 17\(Suppl. 1):13–28.
- KEARNS GL, REED MD: Clinical pharmacolcinetics in Infants and children: a reappraisal Clin. Pharmacokinet. (1989) 17\(Suppl. 1):29–67.
- RANE A: Drug disposition and action in infants and children. In: Pediatric Pharmacology: Therapeutic Princi-ples in Practice (2"d Edition). Yaffe SJ, Aranda JV (Eds.). WB Saunders Co., Philadelphia (1992).
- REED MD, BESUNDER JB: Developmental pharmacology: ontogenic basis of drug disposition. Pediatr. Clin, North Am. (1989) 36(5):1053–1074. A thorough discussion of the factors contributing to age-related differences in drug disposition.
- DREIFUSS FE, LANGER DH: Side-effects of valproate. Am. J. Med. (1988) 84(Suppl. 1A):34–41.
- MATSUDA I, HIGASHI A, INOTSUME N: Physiologic and metabolic aspects of anticonvulsants. Pediatr. Chn. North Am. (1989) 36(5):1099–1111.
- MORROW,B, RICHENS A: Disposition of anticonvulsantsIn childhood. Clin. Pharmacokinet. (1989) 17\(Suppl. 1):89–104.
- KAUFFMAN RE, KEARNS GL: Pharmacolcinetic studies in espaediatric patients: clinical and ethical considerations.Clin. Pharmacokinet. (1992) 23(1):10–29. A practical review of the techniques to ensure the successful completion of ethically defensible studies.
- FOOD AND DRUG ADMINISTRATION: 21 CFR Part 201: Specific requirements on content and format of label-ing for human prescription drugs; revision of the pediatric use subsection in the labeling. Federal Register (1994) 59(238):64240–64250
- COMMIITEE ON BIOETHICS: Informed consent, paren- atal permission and assent in pediatric practice. Pediatr. (1995) 95(2):314–317. A clear definition of the process of obtaining informed consent in paediatrics.